We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+5.72%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$114M
AUM Growth
-$5.43M
(-4.6%)
Cap. Flow
-$5.73M
Cap. Flow
% of AUM
-5.03%
Top 10 Holdings %
Top 10 Hldgs %
31.61%
Holding
148
New
12
Increased
23
Reduced
53
Closed
19
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CGNT
Cogentix Medical, Inc.
CGNT
|
+$1.72M |
| 2 |
SPS Commerce
SPSC
|
+$1.08M |
| 3 |
Aflac
AFL
|
+$991K |
| 4 |
E.W. Scripps
SSP
|
+$875K |
| 5 |
NCR Voyix
VYX
|
+$761K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Xtant Medical Holdings
XTNT
|
+$1.94M |
| 2 |
UPI
UROPLASTY INC-NEW
UPI
|
+$1.66M |
| 3 |
IMRS
IMRIS INC COMMON SHARES (CANADA)
IMRS
|
+$1.23M |
| 4 |
Molson Coors Class B
TAP
|
+$1.18M |
| 5 |
Pentair
PNR
|
+$1.12M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 53.08% |
| 2 | Technology | 14.34% |
| 3 | Industrials | 9.7% |
| 4 | Miscellaneous | 8.71% |
| 5 | Consumer Staples | 4.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Rockwell Medical
RMTI
$32.9M
| $7.8M | 6.85% |
4,399
-1
| -0% | -$1.27K |
|
|
STJ
2
DELISTED
St Jude Medical
STJ
| $6.89M | 6.05% |
94,288
+7,333
| +8% | +$530K |
|
3
NeoGenomics
NEO
$2.32B
| $4.31M | 3.79% |
796,930
-12,250
| -2% | -$63.2K |
|
|
HILL
4
DELISTED
DOT HILL SYSTEMS CORP
HILL
| $3.65M | 3.21% |
596,376
-27,600
| -4% | -$184K |
|
|
CSII
5
DELISTED
Cardiovascular Systems, Inc.
CSII
| $2.59M | 2.28% |
98,000
-1,500
| -2% | -$48.5K |
|
6
Altimmune
ALT
$605M
| $2.18M | 1.92% |
4,044
-252
| -6% | -$127K |
|
7
LeMaitre Vascular
LMAT
$1.84B
| $2.18M | 1.92% |
180,805
-4,444
| -2% | -$43.7K |
|
8
Pfizer
PFE
$159B
| $2.14M | 1.88% |
67,381
+369
| +0.6% | +$12K |
|
9
Apple
AAPL
$4.67T
| $2.13M | 1.87% |
67,820
-3,640
| -5% | -$116K |
|
|
ASRT
10
DELISTED
Assertio
ASRT
| $2.11M | 1.86% |
1,641
+8
| +0.5% | +$11K |
|
11
AtriCure
ATRC
$2.47B
| $2.07M | 1.82% |
84,000
| – | – |
|
|
SVU
12
DELISTED
SUPERVALU Inc.
SVU
| $2.06M | 1.81% |
36,343
+238
| +0.7% | +$15.9K |
|
13
Axogen
AXGN
$2.77B
| $1.99M | 1.75% |
633,250
-17,800
| -3% | -$57.5K |
|
14
Deluxe
DLX
$1.08B
| $1.94M | 1.7% |
31,208
-284
| -0.9% | -$18.7K |
|
15
ePlus
PLUS
$2.28B
| $1.88M | 1.65% |
98,000
-2,000
| -2% | -$41.7K |
|
|
CGNT
16
DELISTED
Cogentix Medical, Inc.
CGNT
| $1.7M | 1.5% |
+1,051,387
| New | +$1.72M |
|
17
Eli Lilly
LLY
$1.05T
| $1.69M | 1.48% |
20,200
| – | – |
|
|
ZIXI
18
DELISTED
Zix Corporation
ZIXI
| $1.64M | 1.44% |
316,989
-5,000
| -2% | -$22.9K |
|
19
UnitedHealth
UNH
$353B
| $1.63M | 1.43% |
13,350
| – | – |
|
|
CASC
20
DELISTED
Cascadian Therapeutics, Inc.
CASC
| $1.51M | 1.33% |
67,402
-3,865
| -5% | -$61.1K |
|
21
CVS Health
CVS
$119B
| $1.49M | 1.31% |
14,183
-134
| -0.9% | -$13.7K |
|
|
HDS
22
DELISTED
HD Supply Holdings, Inc.
HDS
| $1.48M | 1.3% |
41,950
+3,950
| +10% | +$131K |
|
|
WAVX
23
DELISTED
WAVE SYS CORP CL A NEW COM STK (DE)
WAVX
| $1.46M | 1.28% |
250,010
+86,500
| +53% | +$641K |
|
|
24
E.W. Scripps
SSP
$302M
| $1.37M | 1.2% |
59,800
+37,260
| +165% | +$875K |
|
|
SQNM
25
DELISTED
SEQUENOM INC NEW
SQNM
| $1.36M | 1.19% |
445,900
+15,700
| +4% | +$59.1K |
|
Similar funds
AA
WA
AC
BCVI
SWM
HAP
RHIG
CWM
Perkins Capital Management's Q2 2015 Portfolio in Review
As of Q2 2015, Perkins Capital Management held 148 positions worth $114M, down 4.6% from $119M the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Perkins Capital Management withdrew a net $5.73M in Q2 2015, closing 19 positions and reducing 53 holdings. Its most notable exit was Xtant Medical Holdings, an estimated $1.94M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 53% of assets, up from 50% a quarter earlier, followed by Technology and Industrials.
Against the trend, Perkins Capital Management opened a new position in Cogentix Medical, Inc. worth $1.7M.
- Perkins Capital Management's largest Q2 2015 buy was Cogentix Medical, Inc.: 1,051,387 shares worth $1.7M.
- Perkins Capital Management added most to E.W. Scripps in Q2 2015, an estimated $875K increase.
- Perkins Capital Management's biggest Q2 2015 reduction was InnerWorkings, Inc., cutting an estimated $734K.
- Perkins Capital Management fully exited Xtant Medical Holdings in Q2 2015, selling an estimated $1.94M.
- Perkins Capital Management's ten largest holdings make up 32% of its $114M portfolio in Q2 2015.
- Perkins Capital Management opened 12 new positions and closed 19 in Q2 2015.
- Perkins Capital Management's portfolio value fell 4.6% quarter-over-quarter to $114M.
Based on Perkins Capital Management's 13F filing for Q2 2015, filed 29 Jul 2015.